AEGiS-WSJ: AIDS Pledges Leave a Funding Gap Wall Street JournalImportant note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.
Click here to return to Wall Street Journal main menu




DonateNow



AIDS Pledges Leave a Funding Gap

Wall Street Journal - September 7, 2005
Michael M. Phillips, michael.phillips@wsj.com


With Europe in the lead, wealthy nations promised $3.7 billion to replenish the Global Fund to Fight AIDS, Tuberculosis and Malaria, sparking a feud over whether the U.S. is doing its share to combat diseases that together kill six million people a year.

The pledges, made at a donors' conference in London, fell well short of the $7.1 billion the Global Fund calculates it will need for 2006-07.

"The current funding gap will have devastating effects...depriving poor women, men and children from the hope of accessing life-saving prevention and treatment services of TB, malaria and HIV," Anandi Yuvaraj, a member of the Geneva-based Global Fund's board of directors, said in a written statement.

Other officials stressed the positive, saying they were gratified that a number of countries, such as the United Kingdom, had doubled their previous donations. The pledging session was "a very useful and solid step in the right direction," said Richard Feachem, the Global Fund's executive director. "But that gap, between $3.7 billion and $7.1 billion, has got to be filled."

The sum raised in London would be sufficient for the Global Fund to continue projects already begun, but would leave little room for new grants to expand the fund's reach, according to international health officials.

Health activists faulted the Bush administration for pledging just $600 million for the two-year period. France's pledge of $689 million pushed it ahead of the U.S. as the single-largest donor for the period, and European nations as a whole account for at least 60% of the Global Fund's new support. "I wish other donors would make the same commitment," Louis Michel, European Commissioner for Development and Humanitarian Aid, told reporters, echoing language that U.S. policy makers and legislators used when the U.S. was the leading donor.

Ambassador Randall Tobias, who heads President Bush's international AIDS efforts, said the critics ignore the fact that the U.S. remains the world's largest provider of anti-AIDS funding -- the bulk of it through mechanisms other than the Global Fund. In his State of the Union Address in January 2003, Mr. Bush promised a $10 billion increase in U.S. global AIDS spending over five years.

Mr. Tobias said that, including money for the Global Fund, the president will seek $6.5 billion for global AIDS programs between fiscal years 2006 and 2007, a plan that he says will keep the administration on track to fulfill the president's promise. "What we're doing is so much greater than anybody else," he said at the close of the London pledging session.

Under federal law, the U.S. can contribute no more than one-third of the Global Fund resources, a ceiling that Congress imposed in the hopes that it would prompt greater generosity from others. Now the U.S. share of new pledges has fallen to 16% of the total and could fall further as fresh commitments roll in from other countries.

Given past administration rhetoric about its contribution, some AIDS activists believe the U.S. now should increase its contribution to maintain the one-third participation. However, "the signs we're seeing here are that [the U.S. is] moving away from their commitment to one-third," said Richard Burzynski, executive director of the International Council of AIDS Service Organizations, a coalition of thousands of AIDS groups. Mr. Burzynski, who attended the negotiations, said that U.S. negotiators fought hard, but unsuccessfully, to keep the final conference document from including an estimate that the world will have to spend $25.3 billion to successfully combat AIDS, tuberculosis and malaria through 2007.


050907
WJ050901


Copyright © 2005 - The Wall Street Journal. Reproduction of this article (other than one copy for personal reference) must be cleared through the WSJ Permissions Desk.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .